California abortion pill suppliers prepare backup plans for possible mifepristone restrictions
Updated
Updated · Fox News · May 9
California abortion pill suppliers prepare backup plans for possible mifepristone restrictions
12 articles · Updated · Fox News · May 9
With the Supreme Court's temporary stay expiring on 11 May, providers say they can switch within a day to mailing misoprostol instead.
The Fifth Circuit ruling would restore in-person dispensing rules and effectively halt telehealth prescriptions and mail distribution of mifepristone nationwide if allowed to take effect.
Mifepristone is used in nearly two-thirds of US abortions, but the World Health Organization says misoprostol alone is less effective and causes more side effects.
With a key abortion drug at risk, what does the 'backup' medication mean for patient safety?
Could a legal battle over one pill upend the FDA's authority over all approved medicines?
How could a state's financial claims succeed in court where doctors' objections previously failed?
60% of U.S. Abortions in Jeopardy: Supreme Court, Mifepristone Restrictions, and California’s Proactive Defense
Overview
The report highlights the urgent legal battle over mifepristone access, triggered by the 5th Circuit's ruling to require in-person dispensing of the medication, which would greatly restrict abortion access nationwide. In response, manufacturers Danco Laboratories and GenBioPro appealed to the Supreme Court, arguing the ruling caused confusion and regulatory chaos. Justice Alito granted an administrative stay, temporarily blocking the 5th Circuit's decision and restoring mail access to mifepristone. This stay is only temporary, creating uncertainty about the future of medication abortion and prompting states like California to prepare for possible restrictions.